Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Open in API
Filings indexed 509 across all filing types
Latest filing 2017-07-30 Interim / Quarterly Rep…
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
Appendix 4C - quarterly 8 pages 1.0MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'June 2017 Quarterly Report' and includes detailed financial data such as consolidated statements of cash flows for the current quarter and year to date, cash flow from operating, investing, and financing activities, payments to directors, and estimated cash outflows for the next quarter. It also references compliance with Listing Rule 4.7B, which pertains to quarterly reporting for entities listed on the ASX. The document contains substantive financial data and analysis for a period shorter than a full fiscal year (quarterly). It is not merely an announcement or a certification but a comprehensive quarterly financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q4 2017
2017-07-30 English
Digital Health Consortium Formed To Target $3.5B Market 3 pages 144.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 28 July 2017 about the formation of a consortium between Lifespot Health, Unisono, and Icon Global to target the Australian assisted living market. It discusses the consortium's goals, funding applications, and strategic partnerships. There are no financial statements, earnings data, or regulatory filings such as annual or interim reports. The content is a corporate announcement about a strategic business initiative and partnership formation, not a report or financial disclosure. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is a general corporate announcement about a consortium formation and project plans, which aligns best with Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2017-07-27 English
Appendix 3B 17 pages 594.1KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, application for quotation of additional securities, and related agreements. It references ASX rules and includes sections on the number and class of securities issued, terms of securities, issue price, purpose of the issue, and calculation of placement capacity under ASX rules. The document is a formal announcement related to capital raising activities and securities issuance rather than a full financial report or earnings release. It is not an annual report, audit report, or earnings release. It is not a regulatory filing in the sense of compliance or certifications, nor is it a management or governance report. The content clearly fits the category of Capital/Financing Update, which covers updates on company fundraising, financing activities, or capital structure changes. The document length is substantial (15,000 characters), and it contains substantive details about the securities issuance, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement. Therefore, the correct classification is Capital/Financing Update (CAP).
2017-07-03 English
Release of 1,875,000 Shares from Escrow 1 page 40.5
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement regarding the release of 1,875,000 shares from escrow. It references ASX listing rule 3.10A and provides details about the share release date. The document is short (1342 characters) and does not contain financial statements or detailed financial data. It is an announcement about a capital event related to shares being released from escrow, which is a capital structure change. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2017-06-08 English
Results of Meeting 2 pages 61.2KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 30 May 2017, reporting the results of an Annual General Meeting (AGM) of Lifespot Health Limited. It details the resolutions passed by shareholders, including adoption of the remuneration report, re-election of directors, non-executive directors' remuneration, and appointment of auditor. The document provides vote counts and outcomes for each resolution. There is no financial data, no detailed report content, and the document is relatively short (2430 characters). It is clearly an announcement of voting results from the AGM, not the AGM materials themselves or the full annual report. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2017-05-29 English
PEAK-TV Interview 1 page 41.1KB
Regulatory Filings Classification · 90% confidence The document is an ASX announcement dated May 26, 2017, about a PEAK-TV interview featuring company directors and executives discussing digital health. It provides a link to the interview video and includes a brief company description. The document is short (1412 characters) and does not contain any financial data, regulatory filings, or detailed report content. It is an announcement of an interview rather than a financial report or regulatory filing. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2017-05-25 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.